Home / Covid Antigen Tests / Roche – SARS-CoV-2 Rapid Antigen Tests (25 Tests) Sale! Roche – SARS-CoV-2 Rapid Antigen Tests (25 Tests)$375.00 $187.00 Roche – SARS-CoV-2 Rapid Antigen Tests (25 Tests) quantity — OR — Add to cart Category: Covid Antigen Tests Description Intended Use Description **IN STOCK The Roche SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx. This test is an aid in detecting antigens from the SARS-CoV-2 virus in individuals suspected of COVID-19. The kit is ready for use and contains all equipment needed to perform a test. The following components are needed for a test and included in the kit: Test device (individually in a foil pouch with desiccant) Extraction buffer tube Nozzle cap Sterile swab Film (can be attached to the test device when performing outdoor testing) Instructions for use Quick Reference Guide Intended UseThe SARS-CoV-2 Rapid Antigen Test is a lateral flow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worker.